Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
EG.5.1.10ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.5.1.10ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.5.1.10EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.5.1.10EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.5.1.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.5.1.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
FL.2.7.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
FL.2.7.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
FL.2.7.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
FL.2.7.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
FL.2.7.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
FL.2.7.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
FL.2.7.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
FL.2.7.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
EG.9.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
EG.9.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
EG.9.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
EG.9.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
EG.9.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
EG.9.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
EG.9.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
EG.9.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.2.3.22EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.2.3.22EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.2.3.22ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.2.3.22ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.2.3.22EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.2.3.22EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.2.3.22ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.2.3.22ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KP.2.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KP.2.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KP.2.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KP.2.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
KP.2.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
KP.2.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
KP.2.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KP.2.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
unclassifiableEWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-3774.92South Korea
unclassifiableEWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
unclassifiableECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-2177.92Germany
unclassifiableECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
unclassifiableEHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
unclassifiableEHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
unclassifiableENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
unclassifiableENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KS.1.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
KS.1.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
KS.1.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
KS.1.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used